SELLAS Life Sciences Group, Inc. (SLS) Price
SELLAS Life Sciences Group, Inc.
SLS
Dati di mercato non disponibili.
Volume (24h)
--
Offerta circolante
--
Capitalizzazione di mercato
--
Informazioni su SELLAS Life Sciences Group, Inc. (SLS)
Informazioni su SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.
Scarica
App Gemini per dispositivi mobili
Presenta i tuoi amici e guadagna criptovalute.
Se inviti i tuoi amici su Gemini, riceverete entrambi 50 USD in criptovalute se effettueranno operazioni per 100 USD nei primi 30 giorni.
Token di tendenza
Token di tendenza
Gemini ActiveTrader®
Fai trading su SELLAS Life Sciences Group, Inc. sulla piattaforma progettata e realizzata per i trader
Token di tendenza
Token di tendenza
Informazioni su SELLAS Life Sciences Group, Inc. (SLS)
Informazioni su SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company focused on developing novel cancer immunotherapies. Its lead asset, galinpepimut-S, targets a range of cancers including acute myeloid leukemia and mesothelioma. SELLAS operates in a highly specialized field with strong scientific backing and multiple ongoing trials. It aims to deliver targeted, life-extending treatments to patients with unmet medical needs.